Literature DB >> 33107201

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity-modulated radiation therapy era.

Xing-Li Yang1, Guan-Qun Zhou1, Li Lin1, Lu-Lu Zhang2, Fo-Ping Chen1, Jia-Wei Lv1, Jia Kou1, Dan-Wan Wen1, Jun Ma1, Ying Sun1, Yan-Ping Mao1.   

Abstract

We aimed to investigate the prognostic value of radiation interruptions at different times on the overall survival (OS) and disease-free survival (DFS) of patients with nasopharyngeal carcinoma receiving intensity-modulated radiation therapy. Totally, 4510 patients were identified from a well-established big-data intelligence platform. Optimal interruption thresholds were identified using Recursive partitioning analyses. Actuarial rates were plotted using the Kaplan-Meier method and were compared using the log-rank test. Patients with preceding interruptions ≥1 d (5-year OS, 89.6% vs. 85.7%, p < 0.001; 5-year DFS, 81.4% vs. 76.4%, p < 0.001), or latter interruptions ≥4 d (88.4% vs. 82.3%, p < 0.001; 79.2% vs. 75.1%, p = 0.006) showed significant detrimental effects on OS and DFS than patients without those interruptions. However, no significant lower survival was identified in latter interruptions ≥1 d (5-year OS: 89.0% vs. 86.7%, p = 0.053; 5-year DFS, 80.2% vs. 77.8%, p = 0.080). Latter interruptions ≥4 d was an independent unfavorable prognostic factor for OS (HR, 1.404; 95% CI, 1.143-1.723, p = 0.001) and DFS (HR, 1.351; 95% CI, 1.105-1.652, p = 0.003) in multivariate analysis. Radiation interruptions longer than 3 days that occurred in the latter period of treatment with IMRT were independent factors in poorer survival. Efforts are needed to minimize radiation interruptions and improve the timely provision of treatment.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chemotherapy; interruption; nasopharyngeal carcinoma; radiation therapy; survival

Mesh:

Year:  2020        PMID: 33107201      PMCID: PMC7826475          DOI: 10.1002/cam4.3580

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  26 in total

1.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.

Authors:  B Maciejewski; G Preuss-Bayer; K R Trott
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

2.  [The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy].

Authors:  Sheng-fa Su; Fei Han; Chong Zhao; Chun-yan Chen; Wei-wei Xiao; Jia-xin Li; Tai-xiang Lu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2011-02-22

3.  The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.

Authors:  D L Kwong; J S Sham; D T Chua; D T Choy; G K Au; P M Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

4.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

Authors:  Jens Overgaard; Hanne Sand Hansen; Lena Specht; Marie Overgaard; Cai Grau; Elo Andersen; Jens Bentzen; Lars Bastholt; Olfred Hansen; Jørgen Johansen; Lisbeth Andersen; Jan F Evensen
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

5.  The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck.

Authors:  T Herrmann; A Jakubek; K R Trott
Journal:  Strahlenther Onkol       Date:  1994-09       Impact factor: 3.621

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Nasopharyngeal carcinoma incidence and mortality in China, 2013.

Authors:  Kuang-Rong Wei; Rong-Shou Zheng; Si-Wei Zhang; Zhi-Heng Liang; Zhu-Ming Li; Wan-Qing Chen
Journal:  Chin J Cancer       Date:  2017-11-09

8.  A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.

Authors:  Wen-Ze Qiu; Xing-Si Peng; Hai-Qun Xia; Pei-Yu Huang; Xiang Guo; Ka-Jia Cao
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-25       Impact factor: 4.553

9.  Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.

Authors:  Pei-Jing Li; Ting Jin; Dong-Hua Luo; Ting Shen; Dong-Mei Mai; Wei-Han Hu; Hao-Yuan Mo
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

10.  The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.

Authors:  Ji-Jin Yao; Ya-Nan Jin; Si-Yang Wang; Fan Zhang; Guan-Qun Zhou; Wang-Jian Zhang; Jun Ma; Zhen-Yu Qi; Ying Sun
Journal:  BMC Cancer       Date:  2018-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.